Vanguard Asset Management
NEO icon

Vanguard Asset Management’s NeoGenomics NEO Stock Holding History

Vanguard Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
96,186
+17,328
+22% +$167K ﹤0.01% 1728
2026
Q1 		$585K Buy
+78,858
New +$830K ﹤0.01% 2019

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Asset Management's NEO Position: Q2 2026 in Review

Vanguard Asset Management increased its NeoGenomics (NEO) stake by 22% in Q2 2026, buying an estimated $167K and bringing the position to 96,186 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

Vanguard Asset Management first reported a position in NEO in Q1 2026 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Vanguard Asset Management held 96,186 shares of NeoGenomics worth $1.4M as of Q2 2026.
  • Vanguard Asset Management bought 17,328 NeoGenomics shares in Q2 2026, an estimated $167K.
  • NeoGenomics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1728 holding.
  • Vanguard Asset Management first reported a position in NeoGenomics in Q1 2026 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.